FDA expands emergency use of remdesivir in Corona patients

Vastavam web: Gilead Inc said on Friday the U.S. Food and Drug Administration has authorized expanded emergency use for its experimental antiviral COVID-19 treatment, remdesivir. The drug was authorized in May for use in patients with a severe form of the illness, after trial data showed the antiviral drug helped shorten hospital recovery time. Patients with more moderate COVID-19 were shown in studies to have modest benefit after being given the drug, according to a study published last week. The drug can now be used to treat all hospitalized patients with COVID-19, in addition to patients with a severe form of the illness.

Source: Reuters